Authorizes $4,000,000 annually (2024-2026) for a bilateral health tech program with Israel emphasizing AI, drugs, vaccinations, and telemedicine. Requires matching Israeli contributions.
Analysis summaries, actor details, and coverage mappings were LLM-classified and may contain errors.
This is a binding legislative instrument (Congressional bill) that authorizes appropriations with specific legal requirements including mandatory matching contributions from Israel. It uses mandatory language and creates legal obligations for fund allocation.
This document has minimal to no coverage of AI risk domains. It is a funding authorization bill for bilateral health technology cooperation and does not address AI-specific risks, harms, or governance measures. While it mentions AI as one type of health technology eligible for funding, it does not discuss risks associated with AI development or deployment.
This document primarily governs the Health Care and Social Assistance sector by authorizing funding for bilateral development of health technologies including AI. It also has minimal coverage of Scientific Research and Development Services as it funds R&D activities for health technologies.
The document does not specify particular AI lifecycle stages as it is a funding authorization bill. It broadly authorizes grants for development of health technologies including AI, which could encompass multiple lifecycle stages from design through deployment, but does not provide specific governance measures for any particular stage.
The document explicitly mentions artificial intelligence as one type of health technology eligible for funding under the bilateral program. It does not define AI or specify particular types of AI systems, models, or technical thresholds. The focus is on health technologies broadly, with AI listed alongside drugs, vaccinations, diagnostic tests, and telemedicine.
United States Congress; Mr. Pappas and co-sponsors
The bill was introduced in the House of Representatives by Mr. Pappas and numerous co-sponsors, as indicated in the document header.
Secretary of Health and Human Services; Secretary of State
The Secretary of Health and Human Services is designated as the primary authority for administering the program, with the Secretary of State involved in consultation for new programs.
Secretary of Health and Human Services
While not explicitly stated, the Secretary of Health and Human Services would have oversight responsibility for the bilateral program and grant administration.
Grant recipients developing health technologies in bilateral US-Israel program
The bill targets entities that will receive grants for developing health technologies including AI, through a bilateral cooperative program between the US and Israel.